Status:
COMPLETED
Investigation of the Pharmacokinetics and Metabolism of GLPG0634 in Healthy Male Subjects
Lead Sponsor:
Galapagos NV
Conditions:
Healthy
Eligibility:
MALE
40-65 years
Phase:
PHASE1
Brief Summary
This will be a study in 6 healthy male subjects, each receiving a single oral dose of 100 mg \[14C\]-radiolabeled GLPG0634. The study aims to establish the elimination pathways of GLPG0634 and their ...
Eligibility Criteria
Inclusion
- male, between 40 and 65 years of age, inclusive
- within BMI range 18 to 30 kg/m2, inclusive
Exclusion
- Any condition that might interfere with the procedures or tests in this study
- Drug or alcohol abuse
- Smoking
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT01820806
Start Date
March 1 2013
End Date
April 1 2013
Last Update
May 7 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Quotient Clinical
Nottingham, United Kingdom, NG11 6JS